NovAccess Global Inc. (XSNX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Jun 25, 2025, 8:00 PM EDT

NovAccess Global Company Description

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States.

The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer.

NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.

NovAccess Global Inc.
NovAccess Global logo
Country United States
Founded 1997
Industry Biotechnology
Sector Healthcare
Employees 3
CEO Dwain Morris-Irvin

Contact Details

Address:
8584, Washington Street
Chagrin Falls, Colorado Colorado
United States
Phone 213 642 9268

Stock Details

Ticker Symbol XSNX
Exchange OTCMKTS
Fiscal Year October - September
Reporting Currency USD
ISIN Number US67001N1072
SIC Code 2836

Key Executives

Name Position
Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D. Chief Executive Officer, Interim Principal Financial Officer and Director
Dr. Christopher Wheeler Ph.D. President of Stemvax Therapeutics